Current month news & updates
Minor revisions in line with legislation changes
A program overview is now available and registrations remain open for the second annual forum, GMP2, Thursday, 21 November 2019 at the Pullman Melbourne Albert Park.
Summary of our actions following the 2018 TGA stakeholder survey
Decision tree to help you understand whether you can advertise a particular therapeutic good to the public
Additional resources added
Submissions received on the Proposal to introduce a Unique Device Identification (UDI) system for medical devices in Australia have been published.
A complete list of pending changes to the Permissible Indications Determination
Register your interest for the SME Assist workshop in Perth
Update to e-leaflets and to correct the dates sponsors and manufacturers are to comply with implant cards or leaflets
In addition to the legislated requirements, there are other features of leaflet and card design that can be very helpful for patients
Liaison fee is required for all Compliance Verifications (CV) GMP clearance applications using Health Canada Evidence
Updated information about the transitional arrangements for Reformatting Product Information
Advertisers of medicines and medical devices must ensure that they follow our advertising requirements when making natural claims.
You need to understand terms like 'natural' when making decisions about medicines and medical devices
The Therapeutic Goods Administration is part of the Health Products Regulation Group